{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-191783","form_type":"8-K","ticker":"FBRX","cik":"0001419041","company_name":"Forte Biosciences, Inc.","filed_at":"2022-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.684229+00:00","generated_at":"2026-06-24T16:35:27.114596+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Forte Biosciences adopts poison pill rights plan with 10% trigger","bullets":["Board declares dividend of one Right per share of common stock; record date July 21, 2022.","Rights exercisable at $16 per one thousandth of Series A Participating Preferred share.","Rights become exercisable if a person acquires 10% (20% for certain institutional holders) of common stock.","Rights expire on July 12, 2023, redeemable at $0.001 per Right at board's option.","Certificate of Designation for Series A Preferred filed with Delaware Secretary of State."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-191783","json":"https://secwatch.observer/filing/0001193125-22-191783.json","markdown":"https://secwatch.observer/filing/0001193125-22-191783.md","text":"https://secwatch.observer/filing/0001193125-22-191783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/0001193125-22-191783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/d598392d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T16:35:27.114596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}